Treatment of Relapsed/Refractory Hodgkin Lymphoma: Real-World Data from the Czech Republic and Slovakia

Conclusion: Response rates and OS in this analysis of BV in real-world settings in the Czech Republic and Slovakia were consistent with those reported for pivotal clinical trials and from previous studies outside the clinical trial setting. The results support the efficacy of BV for treatment of R/R HL in real-life clinical practice.

Source: Journal of Cancer - December 14, 2019 Category: Cancer & Oncology Authors: Zden ě k Kr á l, Jozef Michalka, Heidi M ó cikov á , Jana Markov á , Alice S ý korov á , David Belada, Alexandra Jungov á , Samuel Vokurka, Marie Luk á š ov á , V í t Proch á zka, Juraj Ď ura š , Roman H á jek, Ladislav Du š ek, Ľ ubo š Tags: Research Paper Source Type: research